Reverse Triple Negative Immune Resistant Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple-negative Breast Cancer
Interventions: DRUG: Choline|DRUG: anti-PD-1 antibody and chemotherapy|DRUG: Sodium Cromoglicate|DRUG: Efavirenz
Sponsor: Fudan University